A BLOOD TEST THAT can predict with 90 percent accuracy if a healthy person will develop mild cognitive impairment (MCI) or Alzheimer’s disease within three years
A BLOOD TEST THAT can predict with 90 percent accuracy if a healthy person will develop mild cognitive impairment (MCI) or Alzheimer’s disease within three years has been discovered and validated by researchers at Georgetown and six other institutions.
The study team explains in the April issue of Nature Medicine (the paper was published online today) how they discovered and then validated a set of 10 lipid biomarkers in the blood that predict both conditions.
The discovery heralds the possible development of earlier treatment options for Alzheimer’s, when therapy could be more effective at slowing or even preventing onset of the disease.
“Our novel blood test offers the potential to identify people at risk for progressive cognitive decline and can change how patients, their families and treating physicians plan for and manage the disorder,” says the study’s corresponding author, Dr. Howard J. Federoff, executive vice president of health sciences at Georgetown University Medical Center.
There is currently no cure or effective treatment for Alzheimer’s disease, which, according to the World Health Organization, is expected to double every 20 years worldwide – from 35.6 million individuals in 2010 to 115.4 million by 2050.
Federoff, also a professor of neurology, explains there have been many efforts to develop drugs to slow or reverse the progression of Alzheimer’s disease, but all of them have failed. He says one reason may be the drugs were evaluated too late in the disease process.
“The preclinical state of the disease offers a window of opportunity for timely disease-modifying intervention, and biomarkers defining this asymptomatic period are critical for successful development and application of these therapeutics,” says Federoff.
‘MAJOR STEP FORWARD’
“The lipid panel was able to distinguish with 90 percent accuracy these two distinct groups – cognitively normal participants who would progress to MCI or AD within two to three years, and those who would remain normal in the near future,” says Federoff, who also serves as executive dean of the School of Medicine.
Researchers say the panel reveals changes in the breakdown of neural cell membranes resulting in 10 identifiable lipids, or metabolites, circulating in the blood. In particular, two of the 10 metabolites have strong links to the neuropathology of Alzheimer’s.
“We consider our results a major step toward the commercialization of a preclinical disease biomarker test that could be useful for large-scale screening to identify at-risk individuals,” Federoff concludes. “We’re intending to design a clinical trial where we’ll use this panel to identify people at high risk for Alzheimer’s to test a therapeutic agent that might delay or prevent the emergence of the disease.”
The Latest on: New blood test
[google_news title=”” keyword=”new blood test” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: New blood test
- Blood test might someday diagnose early MSon April 27, 2024 at 6:10 am
An early marker of multiple sclerosis could help doctors figure out who will eventually fall prey to the degenerative nerve disease, a new study says.
- New blood test could diagnose traumatic brain injuries quicklyon April 26, 2024 at 6:49 pm
The Abbott i-STAT TBI blood test is extraordinarily accurate well above 95% in giving us concrete data about a patient with a concussion or traumatic brain injury ...
- Blood test may be able to detect osteoarthritis 8 years earlier than X-rayon April 26, 2024 at 12:00 pm
A blood test could help predict knee osteoarthritis at least eight years before the signs of the disease show up on X-rays, a new study indicates.
- Blood test can detect signs of knee condition 8 years before X-rayson April 26, 2024 at 11:07 am
A simple blood test can detect early warning signs of a painful condition up to eight years before it appears on X-rays. The accuracy of the test that identifies tell-tale signs of knee osteoarthritis ...
- Blood test powered by AI could catch osteoarthritis 8 years earlier than X-ray, early data showon April 26, 2024 at 11:00 am
A new blood test could determine whether someone will develop knee osteoarthritis up to eight years before structural damage is picked up by an X-ray.
- Blood test finds knee osteoarthritis up to 8 years before it appears on X-rayson April 26, 2024 at 11:00 am
Detecting knee osteoarthritis with a blood test up to eight years before it appears on X-rays -- as researchers have done -- could lead to therapies that delay disease progression and restore joint ...
- Blood Test Detects Knee Osteoarthritis 8 Years Before X-Rayson April 26, 2024 at 11:00 am
Early detection of knee osteoarthritis could lead to therapies that slow progression and restore joint health. A blood test successfully predicted knee osteoarthritis at least eight years before ...
- New Alzheimer’s Blood Test Gets FDA Designation, Maker Seeks to Play ‘Important Role’ in Diagnosison April 24, 2024 at 5:24 pm
A new blood test that could help identify Alzheimer’s earlier from healthcare company Roche has received a Breakthrough Device Designation from the U.S.
- Labcorp, Quest add new blood tests for Alzheimer's, brain tissue damageon April 22, 2024 at 11:16 am
The twin clinical testing giants Labcorp and Quest Diagnostics have each, in the past week, added to their portfolios new blood tests that aim to peek into the workings of the human brain.
- Detecting cancer in minutes possible with just a drop of dried blood and new test, study hintson April 22, 2024 at 9:19 am
Early tests suggest that a new tool that requires only a single drop of blood could detect three of the deadliest forms of cancer.
via Bing News